IP Library Granted Patent US 12,728,209
Granted Patent B2
US 12,728,209 · App. 18/083,359 · Granted Sep 8, 2026

Syringes configured to inhibit forward plunger movement

Inventors: Kevin Nason (Phoenix, AZ); Jeffrey Veloz (San Diego, CA); Bobby E. Rogers (Park City, UT); Nolan Leendert Pupping (Carlsbad, CA)
Assignee: KURIN INC.
A61M5/3134A61B5/153A61M5/31501A61M5/31595A61M2005/3128A61M2005/31508
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,728,209
App. No.
18/083,359
Granted
Sep 8, 2026
Kind
B2
Abstract

Disclosed are systems that include a syringe having a barrel configured to hold a fluid and a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel. The syringe is configured to inhibit forward movement of the plunger. For example, the systems can include mating pockets configured to engage barbs to inhibit forward movement of the plunger.

Claims (47)

1 . A system comprising:

a syringe comprising:

a barrel configured to hold a fluid; and

a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel, the plunger including an interface having an open-ended cylinder with a collection needle and a sampling channel through the plunger, wherein the interface includes one or more mating pockets configured to engage one or more barbs to inhibit forward movement of the plunger,

the syringe thereby being configured to inhibit forward movement of the plunger.

2 . The system of claim 1 , wherein the one or more mating pockets are integrated into the barrel and the one or more barbs are integrated into the plunger.

3 . The system of claim 1 , wherein the one or more mating pockets are integrated into the plunger and the one or more barbs are integrated into the barrel.

4 . The system of claim 1 , wherein the one or more barbs and the one or more mating pockets are arranged to enable a predetermined draw volume.

5 . The system of claim 1 , further comprising an inner wedge adjacent the plunger and an outer wedge adjacent the barrel wherein the inner wedge and outer wedge are configured to provide frictional engagement of the inner wedge and the plunger in response to forward movement of the plunger.

6 . A system comprising:

a syringe comprising:

a barrel configured to hold a fluid; and

a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel, the plunger further comprising:

a plunger seal; and

a wedge at least partially inside the plunger seal and configured to inhibit forward movement of the plunger by increasing friction between the plunger seal and the barrel,

the syringe thereby being configured to inhibit forward movement of the plunger.

7 . The system of claim 6 , further comprising one or more mating pockets configured to engage one or more barbs to inhibit forward movement of the plunger.

8 . The system of claim 7 , wherein the one or more mating pockets are integrated into the barrel and the one or more barbs are integrated into the plunger.

9 . The system of claim 7 , wherein the one or more mating pockets are integrated into the plunger and the one or more barbs are integrated into the barrel.

10 . The system of claim 7 , wherein the one or more barbs and the one or more mating pockets are arranged to enable a predetermined draw volume.

11 . The system of claim 6 , further comprising an inner wedge adjacent the plunger and an outer wedge adjacent the barrel wherein the inner wedge and outer wedge are configured to provide frictional engagement of the inner wedge and the plunger in response to forward movement of the plunger.

12 . A system comprising:

a syringe comprising:

a barrel configured to hold a fluid; and

a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel,

a sampling channel from a tip of the syringe, through the plunger, to an interface having an open-ended cylinder with a collection needle;

a barrel channel from the tip of the syringe into the barrel; and

a check valve in communication with the barrel channel, the check valve configured to check forward expulsion of fluids from the barrel,

the syringe thereby being configured to inhibit forward movement of the plunger.

13 . The system of claim 12 , further comprising one or more mating pockets configured to engage one or more barbs to inhibit forward movement of the plunger.

14 . The system of claim 13 , wherein the one or more mating pockets are integrated into the barrel and the one or more barbs are integrated into the plunger.

15 . The system of claim 13 , wherein the one or more mating pockets are integrated into the plunger and the one or more barbs are integrated into the barrel.

16 . The system of claim 13 , wherein the one or more barbs and the one or more mating pockets are arranged to enable a predetermined draw volume.

17 . The system of claim 12 , further comprising an inner wedge adjacent the plunger and an outer wedge adjacent the barrel wherein the inner wedge and outer wedge are configured to provide frictional engagement of the inner wedge and the plunger in response to forward movement of the plunger.

18 . A system comprising:

a syringe comprising:

a barrel configured to hold a fluid; and

a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel,

a sampling channel from a tip of the syringe, through the plunger, to an interface having an open-ended cylinder with a collection needle;

a barrel channel from the sampling channel into the barrel; and

a check valve in communication with the barrel channel, the check valve configured to check forward expulsion of fluids from the barrel,

the syringe thereby being configured to inhibit forward movement of the plunger.

19 . The system of claim 18 , further comprising one or more mating pockets configured to engage one or more barbs to inhibit forward movement of the plunger.

20 . The system of claim 19 , wherein the one or more mating pockets are integrated into the barrel and the one or more barbs are integrated into the plunger.

21 . The system of claim 19 , wherein the one or more mating pockets are integrated into the plunger and the one or more barbs are integrated into the barrel.

22 . The system of claim 19 , wherein the one or more barbs and the one or more mating pockets are arranged to enable a predetermined draw volume.

23 . The system of claim 18 , further comprising an inner wedge adjacent the plunger and an outer wedge adjacent the barrel wherein the inner wedge and outer wedge are configured to provide frictional engagement of the inner wedge and the plunger in response to forward movement of the plunger.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2023
From: NASON, KEVIN; VELOZ, JEFFREY; ROGERS, BOBBY E.; PUPPING, NOLAN LEENDERT
To: KURIN, INC.
Reel/Frame 065175/0506 →
Continuity (2)
Provisional Application 63291330 · Dec 17, 2021
Related Publication 20230191033A1 · Jun 22, 2023
References Cited (89)
US 1166030A · Willower · 1915 [cited by applicant]
US 3859998A · Thomas · 1975 [cited by applicant]
US 3886930A · Ryan · 1975 [cited by applicant]
US 4207870A · Eldridge · 1980 [cited by applicant]
US 4370987A · Bazell · 1983 [cited by examiner]
US 4373535A · Martell · 1983 [cited by applicant]
US 4690154A · Woodford · 1987 [cited by applicant]
US 4995869A · McCarthy · 1991 [cited by examiner]
US 5037393A · Ellgass · 1991 [cited by examiner]
US 5084017A · Maffetone · 1992 [cited by examiner]
US 5097842A · Bonn · 1992 [cited by applicant]
US 5174301A · Sarstedt · 1992 [cited by applicant]
US 5865803A · Major · 1999 [cited by applicant]
US 5873841A · Brannon · 1999 [cited by applicant]
US 6013037A · Brannon · 2000 [cited by examiner]
US 6913580B2 · Stone · 2005 [cited by applicant]
US 8535241B2 · Bullington · 2013 [cited by applicant]
US 10265007B2 · Bullington · 2019 [cited by applicant]
US 10299713B2 · Patton · 2019 [cited by applicant]
US 10596615B2 · Cavicchia · 2020 [cited by applicant]
US 10624977B2 · Bullington · 2020 [cited by applicant]
US 10881343B2 · Bullington · 2021 [cited by applicant]
US 11213232B2 · Ivosevic · 2022 [cited by applicant]
US 11234626B2 · Bullington · 2022 [cited by applicant]
US 11259727B2 · Bullington · 2022 [cited by applicant]
US 11395612B2 · Bullington · 2022 [cited by applicant]
US 11419531B2 · Bullington · 2022 [cited by applicant]
US 11439332B2 · Bullington · 2022 [cited by applicant]
US 11589843B2 · Bullington · 2023 [cited by applicant]
US 11612340B2 · Bullington · 2023 [cited by applicant]
US 11653863B2 · Bullington · 2023 [cited by applicant]
US 11737693B2 · Bullington · 2023 [cited by applicant]
US 11786155B2 · Bullington · 2023 [cited by applicant]
US 11789017B2 · Bullington · 2023 [cited by applicant]
US 12390596B2 · Nason · 2025 [cited by examiner]
US 20050273019A1 · Conway · 2005 [cited by applicant]
US 20080167577A1 · Weilbacher · 2008 [cited by applicant]
US 20150073348A1 · Bullington · 2015 [cited by applicant]
US 20150105754A1 · Roche · 2015 [cited by applicant]
US 20150351678A1 · Bullington · 2015 [cited by applicant]
US 20180140240A1 · Bullington · 2018 [cited by applicant]
US 20200289039A1 · Bullington · 2020 [cited by applicant]
US 20210275068A1 · Miazga · 2021 [cited by applicant]
US 20220151525A1 · Bullington · 2022 [cited by applicant]
US 20220151527A1 · Bullington · 2022 [cited by applicant]
US 20220160271A1 · Ivosevic · 2022 [cited by applicant]
US 20220304600A1 · Hammer · 2022 [cited by applicant]
US 20220304664A1 · Hammer · 2022 [cited by applicant]
US 20230191033A1 · Nason · 2023 [cited by applicant]
WO 2012012127 · 2012 [cited by applicant]
PCT International Preliminary Examination Report mailed Jun. 27, 2024, International Application No. PCT/IB2022/062419; (14 pages). [cited by applicant]
Abbott Point of Care, Cartridge and Test Information, Art: 714258-010; Rev. Date: Aug. 15, 2016, 1-6 pages. [cited by applicant]
Brecher, Mark E., et al. “Bacterial contamination of blood components.” Clinical microbiology reviews 18.1 (2005): 195-204. [cited by applicant]
Challiner, A., et al. “Venous/arterial blood management protection system.” Anaesthesia 47.2 (1992): 169-169. [cited by applicant]
Closed IV, BD Saf-T-Intima. “Catheter System, Becton, Dickinson and Company, Brochure.” Retrieved from the Internet (Aug. 23, 2019). 4 pages. [cited by applicant]
De Korte, Dirk, et al. “Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections.” Vox sanguinis 83.1 (2002): 13-16. [cited by applicant]
De Korte, Dirk, et al. “Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands.” Transfusion 46.3 (2006): 476-485. [cited by applicant]
Ernst, Dennis J. et al. “NCCLS simplifies the order of draw: a brief history.” MLO: medical laboratory observer 36.5 (2004): 1-5 pages. [cited by applicant]
Gottlieb, T. “Hazards of bacterial contamination of blood products.” Anaesthesia and intensive care 21.1 (1993): 20-23. [cited by applicant]
Hall, Keri K., et al. “Updated review of blood culture contamination.” Clinical microbiology reviews 19.4 (2006): 788-802. [cited by applicant]
Hillyer, Christopher D., et al. “Bacterial Contamination of Blodd Components: Risks, Strategies and Regulation,” Hematology, 2003, pp. 575-589. [cited by applicant]
Li, Yiwen, et al. “Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye Dil.” Nature protocols 3.11 (2008): 1703-1708. [cited by applicant]
Lifesciences, Edwards. “Conservation. Safety. Simplicity. Edwards VAMP and VAMP Jr. Systems.” (2002). 4 pages. [cited by applicant]
Liumbruno, Giancarlo Maria, et al. “Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components.” Blood Transfusion 7.2 (2009): … [cited by applicant]
McDonald, Carl P. “Interventions implemented to reduce the risk of transmission of bacteria by transfusion in the English National Blood Service.” Transfusion Medicine and Hemotherapy 38.4 (2011): 255-258. [cited by applicant]
Murphy, Michael F. “Better Blood Transfusion.” Journal of the Intensive Care Society 4.3 (2003): 78-80. [cited by applicant]
Napolitano, Marcello, et al. “Quality control of bacterial contamination of blood components: the feasibility of diversion system testing.” Blood Transfus 2 (2004): 231-232. [cited by applicant]
NCCLS. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard—Fifth Edition. H3-A5, vol. 23, No. 32. Replaces H3-A4; vol. 18, No. 7. 1-52 pages. http://demo.nextlab.ir/Organizatio… [cited by applicant]
Norberg, Alonna, et al. “Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter.” Jama 289.6 (2003): 726-729. [cited by applicant]
Page, Catherine, et al. “Blood conservation devices in critical care: a narrative review.” Annals of intensive care 3 (2013): 1-6. [cited by applicant]
Palavecino, Elizabeth L., et al. “Detecting bacterial contamination in platelet products.” Clinical laboratory 52.9-10 (2006): 443-456. [cited by applicant]
Patton, Richard G., et al. “Innovation for reducing blood culture contamination: initial specimen diversion technique.” Journal of clinical microbiology 48.12 (2010): 4501-4503. [cited by applicant]
Perez, P., et al. “Multivariate analysis of determinants of bacterial contamination of whole-blood donations.” Vox Sanguinis 82.2 (2002): 55-60. [cited by applicant]
Quilici, Nathalie, et al. “Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units.” Clinical infectious diseases 25.5 (1997): 1066-1070. [cited by applicant]
[cited by applicant]
Sheppard, Chelsea A., et al. “Bacterial contamination of platelets for transfusion: recent advances and issues.” Laboratory Medicine 36.12 (2005): 767-770. [cited by applicant]
Sheppard, et al., Bacterial Contamination of Platelets for Transfusion: Recent Advances and Issues, Labmedicine, vol. 36, No. 12, Dec. 2005 (“Sheppard 2005”). [cited by applicant]
Shulman, Gerald. “Quality of processed blood for autotransfusion.” Journal of Extracorporeal Technology 32.1 (2000): 11-19. [cited by applicant]
Tang, Menglin, et al. “Closed blood conservation device for reducing catheter-related infections in children after cardiac surgery.” Critical Care Nurse 34.5 (2014): 53-60. [cited by applicant]
Van Zundert, Adrien. “New closed IV catheter system.” Acta Anæsthesiologica Belgica 56.3 (2005): 283-285. [cited by applicant]
Weinbaum, Fredric I., et al. “Doing it right the first time: quality improvement and the contaminant blood culture.” Journal of Clinical Microbiology 35.3 (1997): 563-565. [cited by applicant]
Weinstein, Melvin P. “Blood culture contamination: persisting problems and partial progress.” Journal of clinical microbiology 41.6 (2003): 2275-2278. [cited by applicant]
Weinstein, Melvin P. “Current blood culture methods and systems: clinical concepts, technology, and interpretation of results.” Clinical infectious diseases 23.1 (1996): 40-46. [cited by applicant]
Weinstein, Melvin P., et al. “The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults… [cited by applicant]
Zimmon, David S. et al. “Effect of portal venous blood flow diversion on portal pressure.” The Journal of Clinical Investigation 65.6 (1980): 1388-1397. [cited by applicant]
International Search Report and Written Opinion mailed May 4, 2023, International Application No. PCT/IB2022/062419; (23 pages). [cited by applicant]
Office Action (Non-Final Rejection) dated Jun. 11, 2024 for U.S. Appl. No. 18/595,845 (pp. 1-25). [cited by applicant]
Office Action (Final Rejection) dated Sep. 24, 2024 for U.S. Appl. No. 18/595,845 (pp. 1-15). [cited by applicant]
Office Action (Advisory Action) dated Dec. 31, 2024 for U.S. Appl. No. 18/595,845 (pp. 1-15). [cited by applicant]